4//SEC Filing
VAGELOS P ROY 4
Accession 0001883850-21-000032
CIK 0000872589other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:13 PM ET
Size
9.3 KB
Accession
0001883850-21-000032
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Discretionary Transaction
Common Stock
2021-12-16$634.70/sh−19$12,059→ 2,202 total(indirect: By 401(k)) - Discretionary Transaction
Common Stock
2021-12-16$635.03/sh−107$67,948→ 2,095 total(indirect: By 401(k))
Holdings
- 141,630(indirect: by CLAT)
Common Stock
- 37,747(indirect: By Trust)
Common Stock
- 3,609(indirect: By Trust)
Common Stock
- 318,669
Common Stock
Footnotes (2)
- [F1]Represents volume-weighted average price of sales of 107 shares of Company stock on December 16, 2021 at prices ranging from $635.00 to $635.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 16, 2021 at each separate price.
- [F2]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
IncorporatedMD
Related Parties
1- filerCIK 0001013064
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:13 PM ET
- Size
- 9.3 KB